UK markets closed

CMG Pharmaceutical Co., Ltd. (058820.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
2,115.00-10.00 (-0.47%)
At close: 03:30PM KST
Currency in KRW

Valuation measures4

Market cap (intra-day) 293.76B
Enterprise value 251.05B
Trailing P/E 45.98
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.16
Price/book (mrq)1.54
Enterprise value/revenue 3.02
Enterprise value/EBITDA 27.24

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-6.62%
S&P500 52-week change 326.27%
52-week high 32,830.00
52-week low 30.00
50-day moving average 32,174.30
200-day moving average 32,270.80

Share statistics

Avg vol (3-month) 3346.98k
Avg vol (10-day) 3182.76k
Shares outstanding 5138.89M
Implied shares outstanding 6N/A
Float 8107.27M
% held by insiders 125.84%
% held by institutions 13.39%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 328 Aug 2007

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 6.87%
Operating margin (ttm)-4.66%

Management effectiveness

Return on assets (ttm)0.83%
Return on equity (ttm)3.44%

Income statement

Revenue (ttm)93.91B
Revenue per share (ttm)669.17
Quarterly revenue growth (yoy)0.90%
Gross profit (ttm)N/A
EBITDA 5.59B
Net income avi to common (ttm)6.46B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)68.83B
Total cash per share (mrq)475.79
Total debt (mrq)26.12B
Total debt/equity (mrq)13.73%
Current ratio (mrq)4.72
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)3.91B
Levered free cash flow (ttm)1.46B